Posted on February 3rd, 2016 by
After several years of exciting developments in colorectal cancer research and therapy, progress continued throughout 2015. The FDA approved a new drug to treat colorectal cancer, and much research has been done with combination therapies and protocols for treatment. Of great importance, research shows that when colorectal cancer is detected during a screening colonoscopy, patients who screen positive are more likely to live longer than patients who wait for a screening until they have symptoms. Death rates from colorectal cancer have declined in the past 10 years which is thought to be due to increased screening and newer drugs to treat the disease. However, colorectal cancer remains the second leading cause of cancer-related deaths in the U.S.
CancerConnect News coverage of advances in the management of colorectal cancer included the following key developments:
2015 FDA Approvals
2015 Colon Cancer Research News
Screening and Prevention
Knowledge is Power
Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?
Copyright © 2016 CancerConnect. All Rights Reserved.
You must be logged-in to the site to post a comment.